{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-076238","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.316312+00:00","generated_at":"2026-06-10T18:52:58.783557+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Oramed restructures Scilex acquisition; enters non-binding term sheets for Securities Transfer by Sept 19","bullets":["Scilex declared winning bidder for its own securities from Sorrento; aggregate consideration ~$110M plus ~$12.25M legal fee assumption.","Two paths: Hudson Bay funds $115M (Option 1) or Scilex assumes Oramed's Senior DIP Loan and Oramed gets secured Note (Option 2).","If Option 2, Oramed receives 13M warrants at $0.01/sh and 4M warrants at $11.50/sh in Scilex stock; board observer right.","Closing expected Sept 19, 2023; Bankruptcy Court approved term sheets on Sept 12.","Upon closing, Oramed and Sorrento terminate Stock Purchase Agreement and release all claims."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-076238","json":"https://secwatch.observer/filing/0001213900-23-076238.json","markdown":"https://secwatch.observer/filing/0001213900-23-076238.md","text":"https://secwatch.observer/filing/0001213900-23-076238.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390023076238/0001213900-23-076238-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390023076238/ea185123-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T18:52:58.783557+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}